81![PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a](https://www.pdfsearch.io/img/f5b43faf1b3a827554f9cb87a9bc264c.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-05-29 15:15:36
|
---|
82![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTEZLA safely and effectively. See full prescribing information for OTEZLA. OTEZLA® (apremilast) tablets, for oral](https://www.pdfsearch.io/img/eec4ba0fafc60f6479964d4771542e69.jpg) | Add to Reading ListSource URL: www.otezla.comLanguage: English - Date: 2014-07-28 16:03:46
|
---|
83![Xeljanz® (tofacitinib tablets – Pfizer) To Initiate a Coverage Review, Call[removed]OVERVIEW Xeljanz is an inhibitor of the Janus kinases (JAK) pathways approved for the treatment of adults with moderately to s Xeljanz® (tofacitinib tablets – Pfizer) To Initiate a Coverage Review, Call[removed]OVERVIEW Xeljanz is an inhibitor of the Janus kinases (JAK) pathways approved for the treatment of adults with moderately to s](https://www.pdfsearch.io/img/d0fb44fc0cfd58c072c14c39af31dd5d.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-08-12 13:02:45
|
---|
84![Division of Pediatric Drug Development Division of Pediatric Drug Development](https://www.pdfsearch.io/img/ec6e7f6bfcb42287080305bfe522a09f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2005-07-07 15:31:06
|
---|
85![Attention-deficit hyperactivity disorder / Stimulants / Nootropics / Childhood psychiatric disorders / Sleep disorders / Methylphenidate / Attention deficit hyperactivity disorder / Leflunomide / Modafinil / Medicine / Chemistry / Organic chemistry Attention-deficit hyperactivity disorder / Stimulants / Nootropics / Childhood psychiatric disorders / Sleep disorders / Methylphenidate / Attention deficit hyperactivity disorder / Leflunomide / Modafinil / Medicine / Chemistry / Organic chemistry](/pdf-icon.png) | Add to Reading ListSource URL: www.mainecarepdl.orgLanguage: English - Date: 2012-04-02 13:55:27
|
---|
86![Summary of AHRQ’s Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis (RA) in Adults – An Update Jasvinder A. Singh, MD, MPH Davecia R. Cameron, MS Summary of AHRQ’s Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis (RA) in Adults – An Update Jasvinder A. Singh, MD, MPH Davecia R. Cameron, MS](https://www.pdfsearch.io/img/c90ac067c3ea2cdd896e2d1bbcca8112.jpg) | Add to Reading ListSource URL: ce.effectivehealthcare.ahrq.govLanguage: English - Date: 2012-05-31 09:51:18
|
---|
87![NEW EXCEPTION DRUG STATUS LISTINGS: NEW EXCEPTION DRUG STATUS LISTINGS:](https://www.pdfsearch.io/img/4c733ca1c23b8e557ec2902d46cebd0b.jpg) | Add to Reading ListSource URL: formulary.drugplan.health.gov.sk.caLanguage: English - Date: 2014-06-26 15:57:54
|
---|
88![#84 August, 2000 QUARTERLY UPDATE TO THE 50th EDITION #84 August, 2000 QUARTERLY UPDATE TO THE 50th EDITION](https://www.pdfsearch.io/img/9b740640fc56f1be0371bc12fad45092.jpg) | Add to Reading ListSource URL: formulary.drugplan.health.gov.sk.caLanguage: English - Date: 2014-06-26 15:57:56
|
---|
89![The New Brunswick Drug Plans Special Authorization Criteria ABATACEPT (ORENCIA) 250mg vial for intravenous injection • For the treatment of Juvenile Rheumatoid Arthritis: The New Brunswick Drug Plans Special Authorization Criteria ABATACEPT (ORENCIA) 250mg vial for intravenous injection • For the treatment of Juvenile Rheumatoid Arthritis:](https://www.pdfsearch.io/img/667462599b3e7ac7f976aba1c3bf191e.jpg) | Add to Reading ListSource URL: www.gnb.caLanguage: English - Date: 2014-09-05 11:31:26
|
---|
90![NEW EXCEPTION DRUG STATUS LISTINGS: NEW EXCEPTION DRUG STATUS LISTINGS:](https://www.pdfsearch.io/img/e650dbd202ebcd1f68e3cfeb87b3536c.jpg) | Add to Reading ListSource URL: formulary.drugplan.health.gov.sk.caLanguage: English - Date: 2014-06-26 15:57:57
|
---|